Ready to Measure Impact? The Introduction of Rotavirus Vaccine in India. (Q50776961)

19 March 2018

editorial

0 references

title

Ready to Measure Impact? The Introduction of Rotavirus Vaccine in India. (English)

1 reference

19 March 2018

1 reference

1 reference

2

Soumya Swaminathan

1 reference

19 March 2018

Rashmi Arora

1

1 reference

19 March 2018

publication date

1 July 2016

1 reference

19 March 2018

published in

Indian Pediatrics

1 reference

19 March 2018

volume

53

1 reference

19 March 2018

issue

7

1 reference

19 March 2018

page(s)

565-567

1 reference

19 March 2018

https://scigraph.springernature.com/pub.10.1007/s13312-016-0889-x

exact match

0 references

cites work

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Diversity of circulating rotavirus strains in children hospitalized with diarrhea in India, 2005-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Potential intussusception risk versus benefits of rotavirus vaccination in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-016-0889-X

10.1007/S13312-016-0889-X

21 January 2018

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018